Oxaliplatin aggravates hepatic oxidative stress, inflammation and fibrosis in a non-alcoholic fatty liver disease mouse model

Oxaliplatin (OXA)-based chemotherapy is widely used in the treatment of gastrointestinal tumors; however, it is associated with chemotherapy-associated liver injury. Whether OXA induces liver injury and aggravates the already existing hepatic oxidative stress, inflammation and fibrosis in non-alcoho...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yulei, Lin, Youzhi, Huang, Xiaoqing, Wu, Shengming, Wei, Jian, Yang, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488186/
https://www.ncbi.nlm.nih.gov/pubmed/30942432
http://dx.doi.org/10.3892/ijmm.2019.4154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488186/
https://www.ncbi.nlm.nih.gov/pubmed/30942432
http://dx.doi.org/10.3892/ijmm.2019.4154

Ejemplares similares